Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Aadi Bioscience, Inc. (AADI) Insider Trading Activity
Healthcare • Biotechnology • 70 employees
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Total Value
-$191,683.84
Total Shares
-97,131
Average Trade Value
-$23,960.48
Most Active Insider
Desai Neil
Total Activity: $182,887
Largest Single Transaction
$68,316
by Desai Neil on Sep 3, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Chief Executive Officer
|
Oct 3, 2024 | 9,689 | $18,797 | 22,869 (-42.4%) | Sale | |
|
Chief Executive Officer
|
Oct 2, 2024 | 32,558 | $10,000 | 32,558 (+100.0%) | Exercise/Conversion | |
|
Executive Chairman
|
Sep 3, 2024 | 40,000 | $68,316 | 1,171,543 (-3.4%) | Sale | |
|
Executive Chairman
|
Aug 5, 2024 | 5,652 | $7,595 | 1,211,543 (-0.5%) | Sale | |
|
Executive Chairman
|
Aug 2, 2024 | 18,933 | $26,705 | 1,217,195 (-1.6%) | Sale | |
|
Executive Chairman
|
Aug 1, 2024 | 15,415 | $23,055 | 1,236,128 (-1.2%) | Sale | |
|
Executive Chairman
|
Jul 2, 2024 | 8,652 | $11,612 | 1,251,543 (-0.7%) | Sale | |
|
Executive Chairman
|
Jul 1, 2024 | 31,348 | $45,605 | 1,260,195 (-2.5%) | Sale |